The Roadmap The EMBARC project seeks to promote clinical research in bronchiectasis and to build research capacity in Europe.A key task in driving future development will be identifying the areas of greatest clinical and academic priority for the next decade. …
The EMBARC registry This is the core study of the EMBARC project and is focussed on the creation of a pan-European registry for patients with bronchiectasis. Find more details about the EMBARC registry and sign up here Additional studies The …
Facilitating Research Into Existing National DataSets (FRIENDS) Many countries and specialists centres have had established electronic databases or have performed longditudinal observational studies over the past decade. The EMBARC registry is a prospective registry of newly identified patients. The purpose …
Download Winter 2016 Download October 2016 Download September 2016 Download August 2016 Download July 2016 Download June 2016 Download May 2016 Download April 2016 Download March 2016 Download February 2016 Download January 2016
Download September 2017 Download August 2017 Download Summer 2017 Download May 2017 Download April 2017 Download March 2017 Download February 2017 Download January 2017
EMBARC is a pan-European network. Countries currently participating in the EMBARC initiative include: Austria Belgium Bulgaria Croatia Czech Republic Denmark Finland France Germany Greece Ireland Israel Italy Latvia Lithuania Macedonia Malta Moldova Netherlands Poland Portugal Romania Russia Serbia Slovakia Slovenia …
EMBARC wishes to acknowledge generous support in the form of funding, logistical and intellectual support The European Union IMI initiative The European Respiratory Society The European Lung Foundation The Zambon Group Janssen Pharmaceutica Chiesi Ltd Insmed Inc. AstraZeneca Grifols Novartis Pharma …
The EMBARC (European Multicentre Bronchiectasis Audit and Research Collaboration) network was established in 2012 to facilitate multidisciplinary collaborative research in non-CF bronchiectasis. The aims of the EMBARC group are To create the EMBARC registry, a European bronchiectasis registry to facilitate …
EMBARC Transparency Notice In this research register we (the Sponsor, University of Dundee) will use de-identified information from you and your medical records. We will only use information that we need for the research register. Only your local research team …
Bronchiectasis is an orphan disease, with few evidence based treatments and a lack of data regarding epidemiology, co-morbidities, pathophysiology, severity and prognosis. There have been few longitudinal or cross-sectional studies in bronchiectasis. To give truly meaningful and generalizable results, a …
Contact
EMBARC
Carl-Neuberg-Straße 1, 30625 Hannover, Germany
[email protected]
Opening hours
Mon - Fr 10:00 - 17:00
Sat - 10:00 - 15:00
Sun - 10:00 - 13:00
Important links